BlueYard Capital logo

BlueYard Capital

Europe, Berlin, Germany, Berlin

Description

BlueYard seeks to invest in founders with transforming ideas that decentralize markets.

Investor Profile

BlueYard Capital has made 83 investments, with 10 in the past 12 months and 39% as lead.

Stage Focus

  • Seed (43%)
  • Series A (28%)
  • Series Unknown (17%)
  • Pre Seed (8%)
  • Initial Coin Offering (1%)
  • Angel (1%)
  • Series B (1%)

Country Focus

  • United States (39%)
  • Germany (22%)
  • United Kingdom (8%)
  • France (7%)
  • The Netherlands (6%)
  • Switzerland (5%)
  • Iceland (2%)
  • Spain (1%)
  • Poland (1%)
  • Canada (1%)

Industry Focus

  • Software
  • Biotechnology
  • Blockchain
  • Cryptocurrency
  • Manufacturing
  • Internet
  • Food And Beverage
  • Information Technology
  • Web3
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BlueYard Capital frequently co-invest with?

Sequoia Capital
North America, California, United States, Menlo Park
Co-Investments: 4
Protocol Labs
North America, California, United States, San Francisco
Co-Investments: 4
Possible Ventures
Europe, Bayern, Germany, Munich
Co-Investments: 7
Amino Collective
Europe, Berlin, Germany, Berlin
Co-Investments: 3
Alven
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Union Square Ventures
North America, New York, United States, New York
Co-Investments: 4
Inflection.xyz
North America, Massachusetts, United States, Boston
Co-Investments: 4
EQT Ventures
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 6
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 6
Acequia Capital (AceCap)
North America, Washington, United States, Seattle
Co-Investments: 12

Which angels does BlueYard Capital often collaborate with?

CE
North America, California, United States, San Francisco
Shared Deals: 1
Henok Tekle
North America, NA - Puerto Rico, Puerto Rico, San Juan
Shared Deals: 1
David J. La Placa
North America, California, United States, San Francisco
Shared Deals: 1
RK
North America, California, United States
Shared Deals: 2
MA
North America, California, United States, San Francisco
Shared Deals: 1
JS
North America, Wyoming, United States, Cheyenne
Shared Deals: 1
AW
North America, New York, United States, New York
Shared Deals: 1
TH
Europe, England, United Kingdom, London
Shared Deals: 4
CS
North America, Washington, United States, Kirkland
Shared Deals: 3
Jason Fang
Asia, Hong Kong
Shared Deals: 1

What are some of recent deals done by BlueYard Capital?

Privy

New York, New York, United States

Simple APIs to help developers manage user data privately in Web3

Cyber SecurityDeveloper APIsWeb3
Series UnknownMar 19, 2025
Amount Raised: $15,000,000
Castelion

El Segundo, California, United States

Castelion is a defense tech company that applies modern hardware development and manufacturing processes to national security challenges.

AerospaceGovernmentManufacturingMilitaryNational Security
Series AJan 29, 2025
Amount Raised: $70,000,000
Cryptio

Paris, Ile-de-France, France

Cryptio is a fintech and SaaS company that offer accounting, audit and tax software for digital assets.

AccountingAnalyticsBlockchainCryptocurrencyFinTech
Series AJan 29, 2025
Amount Raised: $15,000,000
SeeQC

Elmsford, New York, United States

SeeQC is a semiconductor company that develops quantum computing systems and offers chip fabrication services to businesses.

ElectronicsInfrastructureManufacturingQuantum ComputingSemiconductor
Series AJan 14, 2025
Amount Raised: $30,000,000
bit.bio

Cambridge, Cambridgeshire, United Kingdom

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

BiotechnologyCommercialHealth Care
Series UnknownDec 16, 2024
Amount Raised: $30,000,000
Clock Bio

Cambridge, Cambridgeshire, United Kingdom

Clock Bio operates as a biotech company.

BiotechnologyMedical
SeedOct 9, 2024
Amount Raised: $5,300,000
CPTx

Planegg, Bayern, Germany

CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases.

BiotechnologyGeneticsTest and Measurement
Series UnknownSep 12, 2024
Amount Raised: $29,000,000
ExpressionEdits

Haverhill, Suffolk, United Kingdom

ExpressionEdits is a biotechnology company that redesigns synthetic DNA instructions using AI, focusing on protein expression.

Artificial Intelligence (AI)BiotechnologyGenetics
SeedMay 29, 2024
Amount Raised: $13,000,000
Insempra

Planegg, Bayern, Germany

Insempra is a biotechnology-powered company enabling businesses to transform their ingredient lists with superior bio-based products.

BeautyBiotechnologyFood and BeverageManufacturingPersonal Care and Hygiene
Series AMay 8, 2024
Amount Raised: $20,000,000
Transcripta Bio

Palo Alto, California, United States

Transcripta Bio is a company that focuses on drug development at a size and pace never seen before, with a lower risk.

BiotechnologyMedical
Series UnknownApr 29, 2024
Amount Raised: $10,000,000